Stock 688488 JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Jiangsu Aidea Pharmaceutical Co., Ltd.

Equities

688488

CNE1000041S6

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
14.98 CNY -0.99% Intraday chart for Jiangsu Aidea Pharmaceutical Co., Ltd. -6.96% +19.74%
04-25 Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-23 Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aidea Pharmaceutical, Subsidiaries Get Nod to Trial Anti-HIV Drug
MT
Aidea Pharmaceutical Unit Scraps Transfer Deal with Lixin Biotechnology for Anti-Tumor Drug
MT
Aidea Pharmaceutical's HIV Drug Granted Priority Review in China
MT
China's Drug Regulator Selects Aidea Pharmaceutical's HIV Drug for Priority Review
MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jiangsu Aidea Applies For 50 Million Yuan Bank Credit
MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Aidea Pharma to Apply For 50 Million Yuan Bank Loan
MT
Jiangsu Aidea Pharma to Apply For 60 Million Yuan Bank Loan
MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jiangsu Aidea Pharma to Provide Services to China Medicines and Health Products in Three-Year Agreement
MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jiangsu Aidea Pharma Sees Larger Loss in 2022
MT
Jiangsu Aidea Pharma Registers HIV Tablets
MT
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jiangsu Aidea Pharmaceutical Co., Ltd. agreed to acquire 19.9646% stake in Nanjing Nanda Pharmaceutical Co., Ltd. from Jiangsu Sheng Feng Medical Technology Company Limited for CNY 86 million.
CI
Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688488 Stock
  4. News Jiangsu Aidea Pharmaceutical Co., Ltd.